Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

EIF4EBP1 → TMEM39B

GSE10780_egf1520 - GSE10780 - SiGN-BN HC+Bootstrap	Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
GSE11582_egf1520 - GSE11582 - SiGN-BN HC+Bootstrap	Genetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
GSE14208_egf1520 - GSE14208 - SiGN-BN HC+Bootstrap	Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy
GSE14210_egf1520 - GSE14210 - SiGN-BN HC+Bootstrap	Expression data from human endoscopic biopsy samples
GSE15641_egf1520 - GSE15641 - SiGN-BN HC+Bootstrap	Gene signatures of progression and metastasis in renal cell cancer
GSE18520_egf1520 - GSE18520 - SiGN-BN HC+Bootstrap	Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas
GSE18521_egf1520 - GSE18521 - SiGN-BN HC+Bootstrap	A gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2
GSE20842_egf1520 - GSE20842 - SiGN-BN HC+Bootstrap	Mutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
GSE25428_egf1520 - GSE25428 - SiGN-BN HC+Bootstrap	Gene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor